Found vs HumeCare+ — Biology-First Plans vs Bundled GLP-1
Found vs HumeCare+ compares two different telehealth weight loss approaches: Found emphasizes a biology-first, personalized medically supervised program that accepts most insurance and starts as low as $39, while HumeCare+ sells a bundled GLP-1 protocol starting at $199/month with added glycine and vitamins and a 10% or your money back promise. Early verdict: choose Found for insurance-friendly, lower entry pricing and biology-centered planning; choose HumeCare+ if you want a GLP-1 protocol with muscle-support ingredients and body composition tracking.
Key differences at a glance: Found vs HumeCare+
Below are the most distinctive differences supported by the source evidence: pricing and insurance; program approach and personalization; supportive ingredients and tracking; clinician access and guarantees; and regulatory warnings about compounded medications.
1. Pricing and insurance handling
Found advertises “get started for as low as $39” and highlights that most insurance is now accepted. Found states it handles insurance paperwork and lists multiple pricing notes including plans starting at $49/month when billed annually and examples like $50/mo for some brand options through Medicare programs subject to eligibility. HumeCare+ lists semaglutide from $199/month and tirzepatide plus B12 and glycine from $299/month. HumeCare+ is described as cash-pay pricing shown as promotional and may change. If insurance acceptance and lower starting price matter, Found is the evidence-backed option; if you prefer a cash-pay bundled program, HumeCare+ shows higher starting prices.
See Found pricing and insurance options
2. Program approach and medication options
Found positions itself as biology-first: it conducts a medical evaluation and builds a personalized program around hormones, blood sugar, sleep, and behavior, and lists semaglutide and tirzepatide among available options, including compounded formulations. HumeCare+ packages physician-prescribed compounded semaglutide or tirzepatide with supportive ingredients, dose set by your provider, and continuous physician optimization via an app. Both providers offer compounded GLP-1 options; neither source claims compounded medications are FDA-approved. Found emphasizes whole-body personalization beyond medication; HumeCare+ emphasizes a standardized protocol plus ongoing optimization.
3. Supportive therapies, tracking, and outcomes
HumeCare+ explicitly includes glycine, vitamins B6 and B12 built into the formulation and monthly body composition scans to track lean mass versus fat. HumeCare+ advertises a 10% or your money back promise over six months, subject to terms. Found focuses on a holistic plan that targets hormones, metabolism, lifestyle, and behavioral factors. HumeCare+ highlights app tracking, body-composition scans, and built-in supportive ingredients as ways to address muscle loss and side effects; Found highlights personalized medically supervised plans and insurance handling.
View HumeCare+ protocols and scans
4. Clinician access, delivery, and guarantees
HumeCare+ advertises unlimited clinician access, a U.S. care team available 24/7, free next-day delivery, and cancel anytime. It also promotes a money-back promise if you do not lose at least 10% body weight in six months, with eligibility and documentation requirements. Found states Rx is subject to provider review and clinical eligibility and that it handles insurance paperwork; Found also notes results vary by individual and includes offer details and limitations for discounts and Medicare bridge programs. Delivery and clinician access differ: HumeCare+ emphasizes 24/7 clinician support and next-day shipping while Found emphasizes insurance integration and personalized medical evaluation.
5. Safety and regulatory notes
Both sources include regulatory language that compounded GLP-1 medications are not FDA-approved and are not evaluated by the FDA for safety, effectiveness, or quality. Found adds that certain medications are FDA-approved for conditions other than weight and that Found is not affiliated with or endorsed by manufacturers of brand-name GLP-1s. HumeCare+ notes that compounded medications are dispensed from U.S. pharmacies licensed and inspected by state Boards of Pharmacy and reiterates that compounded medications are not FDA-evaluated.
Comparison table: Found vs HumeCare+
| Criteria | Found | HumeCare+ |
|---|---|---|
| Starting price | Get started for as low as $39 | Semaglutide from $199/mo; tirzepatide + B12 + glycine from $299/mo |
| Insurance | Most insurance now accepted; Found handles paperwork | Cash-pay; promotional pricing shown may change |
| Program focus | Biology-first personalized medical plan | Bundled GLP-1 protocol with supportive ingredients and app |
| Supportive therapies | Holistic lifestyle and metabolic targeting | Glycine, B6, B12 included; body-composition scans |
| Clinician access & delivery | Provider review and clinical eligibility; insurance handling | Unlimited clinician access 24/7; free next-day delivery |
| Guarantee | No money-back promise captured | 10% or your money back over six months, terms apply |
| Regulatory note | Compounded GLP-1s not FDA-approved or evaluated | Compounded medications not FDA-evaluated for safety or quality |
How to choose: Found vs HumeCare+
Choose Found if you want insurance acceptance, a lower entry price like “as low as $39”, and a biology-first, personalized medically supervised program that integrates hormones, metabolism, sleep, and behavior into treatment planning. Choose HumeCare+ if you want a bundled GLP-1 protocol with glycine and vitamins B6 and B12, monthly body composition scans, 24/7 clinician access, next-day delivery, and a 10% or your money back promise over six months, subject to the provider terms.
Explore HumeCare+ plans and promise
Compare Found plans and start an evaluation
Found vs HumeCare+ shows two different trade offs: lower starting pricing and insurance integration with Found versus HumeCare+ focus on a protocol that layers muscle-supportive ingredients, body-composition tracking, and a money-back promise. Both sources note compounded medications are not FDA-approved and that clinical eligibility and provider review determine access.